Innoviva (INVA) EBT Margin Growth (3y) (2014 - 2026)
Innoviva (INVA) EBT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | -198,803.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -198,803.00 |
| Dec 31, 2025 | -6,217.00 |
| Sep 30, 2025 | -8,800.00 |
| Jun 30, 2025 | -42,651.00 |
| Mar 31, 2025 | -205,334.00 |
| Dec 31, 2024 | 327,960.00 |
| Sep 30, 2024 | -13,205.00 |
| Jun 30, 2024 | -501,299.00 |
| Mar 31, 2024 | -643,471.00 |
| Dec 31, 2023 | -2.95 Mn |
| Sep 30, 2023 | 224.00 |
| Jun 30, 2023 | 5,573.00 |
| Mar 31, 2023 | 210,680.00 |
| Dec 31, 2022 | -160,562.00 |
| Sep 30, 2022 | 4,481.00 |
| Jun 30, 2022 | 41,078.00 |
| Mar 31, 2022 | 192,186.00 |
| Dec 31, 2021 | -462,941.00 |
| Sep 30, 2021 | 5,547.00 |
| Jun 30, 2021 | 488,927.00 |